Chemical Structure : NS3623
CAS No.: 343630-41-1
Catalog No.: PC-60833Not For Human Use, Lab Use Only.
NS3623 is a novel human RBC Cl-conductance blocker (IC50=210 nM) and HERG channel activitor (EC50=79.4 uM, HERG1 channel activation).
Packing | Price | Stock | Quantity |
---|---|---|---|
5 mg | $88 | In stock | |
10 mg | $138 | In stock | |
25 mg | $238 | In stock | |
50 mg | $388 | In stock | |
100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
NS3623 is a novel human RBC Cl-conductance blocker (IC50=210 nM) and HERG channel activitor (EC50=79.4 uM, HERG1 channel activation).
NS-3623 inhibits RBC g(Cl) after oral administration to normal mice (ED50= 25 mg/kg), ameliorates erythrocyte dehydration in transgenic SAD mice.
NS-3623 increases the macroscopic current conducted by the hERG channels by increasing the time constant for channel inactivation.
NS-3623 affects native I(Kr), decreases QT variability and distinctly decreases the occurrence of extrasystoles in the acutely bradypaced hearts.
M.Wt | 427.185 | |
Formula | C15H10BrF3N6O | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
N-(4-bromo-2-(1H-tetrazol-5-yl)-phenyl)-N'-(3'-trifluoromethylphenyl)urea |
1. Bennekou P, et al. Blood. 2001 Mar 1;97(5):1451-7.
2. Hansen RS, et al. Mol Pharmacol. 2006 Oct;70(4):1319-29.
3. Hansen RS, et al. J Pharmacol Exp Ther. 2007 Jun;321(3):996-1002.
4. Hansen RS, et al. J Cardiovasc Pharmacol. 2008 Jul;52(1):35-41.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright